-
1
-
-
31344448805
-
Second-line treatment for advanced non-small cell lung cancer: A systematic review
-
Barlesi F, Jacot W, Astoul P, et al. Second-line treatment for advanced non-small cell lung cancer: a systematic review. Lung Cancer 2006;51:159-172.
-
(2006)
Lung Cancer
, vol.51
, pp. 159-172
-
-
Barlesi, F.1
Jacot, W.2
Astoul, P.3
-
2
-
-
34247871456
-
Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: A systematic review and practice guideline
-
Noble J, Ellis PM, Mackay JA, et al. Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline. J Thoracic Oncol 2006;1:1042-1058.
-
(2006)
J Thoracic Oncol
, vol.1
, pp. 1042-1058
-
-
Noble, J.1
Ellis, P.M.2
Mackay, J.A.3
-
3
-
-
2442661845
-
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
-
Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004;22:1589-1597.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1589-1597
-
-
Hanna, N.1
Shepherd, F.A.2
Fossella, F.V.3
-
4
-
-
58149206195
-
Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS)
-
Hollen PJ, Gralla RJ, Kris MG, et al. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 1993;29A(Suppl 1):S51-S58.
-
(1993)
Eur J Cancer
, vol.29 A
, Issue.SUPPL. 1
-
-
Hollen, P.J.1
Gralla, R.J.2
Kris, M.G.3
-
5
-
-
0028267598
-
Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale
-
Hollen PJ, Gralla RJ, Kris MG, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer 1994;73:2087-2098.
-
(1994)
Cancer
, vol.73
, pp. 2087-2098
-
-
Hollen, P.J.1
Gralla, R.J.2
Kris, M.G.3
-
6
-
-
7444271057
-
Does second-line therapy for non-small cell lung cancer (NSCLC) result in symptom palliation? Analysis of 484 patients from a randomized trial of pemetrexed vs docetaxel
-
de Marinis F, Pereira JR, Park K, et al. Does second-line therapy for non-small cell lung cancer (NSCLC) result in symptom palliation? Analysis of 484 patients from a randomized trial of pemetrexed vs docetaxel. J Clin Oncol 2004;22(14 Suppl):7035.
-
(2004)
J Clin Oncol
, vol.22
, Issue.14 SUPPL.
, pp. 7035
-
-
de Marinis, F.1
Pereira, J.R.2
Park, K.3
-
7
-
-
33748445361
-
-
Bezjak A, Tu D, Seymour L, et al. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol 2006;24:3831-3837. Erratum: J Clin Oncol 2007;25:3831.
-
Bezjak A, Tu D, Seymour L, et al. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol 2006;24:3831-3837. Erratum: J Clin Oncol 2007;25:3831.
-
-
-
-
8
-
-
37549007521
-
Delay in time to worsening of symptoms (TWS) of advanced non-small cell lung cancer (NSCLC) using gemcitabine (gem) maintenance therapy
-
Peterson P, Zwitter M, Krzakowski M, et al. Delay in time to worsening of symptoms (TWS) of advanced non-small cell lung cancer (NSCLC) using gemcitabine (gem) maintenance therapy. J Clin Oncol 2006;24(18 Suppl):7140.
-
(2006)
J Clin Oncol
, vol.24
, Issue.18 SUPPL.
, pp. 7140
-
-
Peterson, P.1
Zwitter, M.2
Krzakowski, M.3
-
9
-
-
0027076295
-
Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria
-
Green S, Weiss GR. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 1992;10:239-253.
-
(1992)
Invest New Drugs
, vol.10
, pp. 239-253
-
-
Green, S.1
Weiss, G.R.2
-
10
-
-
34250874101
-
Evaluating clinical versus statistical significance with the LCSS quality of life instrument and the Karnofsky Performance Status (KPS)
-
Hollen PJ, Gralla RJ. Evaluating clinical versus statistical significance with the LCSS quality of life instrument and the Karnofsky Performance Status (KPS). Lung Cancer 2000;29(Suppl 1):107.
-
(2000)
Lung Cancer
, vol.29
, Issue.SUPPL. 1
, pp. 107
-
-
Hollen, P.J.1
Gralla, R.J.2
-
11
-
-
0036195669
-
Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures
-
Guyatt GH, Osoba D, Wu AW, et al. Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371-383.
-
(2002)
Mayo Clin Proc
, vol.77
, pp. 371-383
-
-
Guyatt, G.H.1
Osoba, D.2
Wu, A.W.3
-
12
-
-
0037980149
-
Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation
-
Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582-592.
-
(2003)
Med Care
, vol.41
, pp. 582-592
-
-
Norman, G.R.1
Sloan, J.A.2
Wyrwich, K.W.3
-
13
-
-
11244320698
-
Quality of life as a clinical trial endpoint: Determining the appropriate interval for repeated assessments in patients with advanced lung cancer
-
Hollen PJ, Gralla RJ, Rittenberg CN. Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer. Support Care Cancer 2004;12:767-773.
-
(2004)
Support Care Cancer
, vol.12
, pp. 767-773
-
-
Hollen, P.J.1
Gralla, R.J.2
Rittenberg, C.N.3
-
14
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
15
-
-
0020144696
-
A concordance test for independence in the presence of censoring
-
Oakes D. A concordance test for independence in the presence of censoring. Biometrics 1982;38:451-455.
-
(1982)
Biometrics
, vol.38
, pp. 451-455
-
-
Oakes, D.1
-
16
-
-
0032917537
-
Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS)
-
Hollen PJ, Gralla RJ, Kris MG, et al. Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 1999;7:140-148.
-
(1999)
Support Care Cancer
, vol.7
, pp. 140-148
-
-
Hollen, P.J.1
Gralla, R.J.2
Kris, M.G.3
-
17
-
-
1642575171
-
Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: Results of a prospective, randomized phase III trial
-
Dancey J, Shepherd FA, Gralla RJ, et al. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. Lung Cancer 2004;43:183-194.
-
(2004)
Lung Cancer
, vol.43
, pp. 183-194
-
-
Dancey, J.1
Shepherd, F.A.2
Gralla, R.J.3
-
18
-
-
0028275927
-
The EORTC QLQ-LC13: A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials
-
Bergman B, Aaronson NK, Ahmedzai S, et al. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 1994;30A:635-642.
-
(1994)
Eur J Cancer
, vol.30 A
, pp. 635-642
-
-
Bergman, B.1
Aaronson, N.K.2
Ahmedzai, S.3
-
19
-
-
0031972496
-
Interpreting the significance of changes in health-related quality-of-life scores
-
Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139-144.
-
(1998)
J Clin Oncol
, vol.16
, pp. 139-144
-
-
Osoba, D.1
Rodrigues, G.2
Myles, J.3
-
20
-
-
34250026980
-
Effects of sorafenib on symptoms and quality of life: Results from a large randomized placebo-controlled study in renal cancer
-
Bukowski R, Cella D, Gondek K, et al. Effects of sorafenib on symptoms and quality of life: Results from a large randomized placebo-controlled study in renal cancer. Am J Clin Oncol 2007;30:220-227.
-
(2007)
Am J Clin Oncol
, vol.30
, pp. 220-227
-
-
Bukowski, R.1
Cella, D.2
Gondek, K.3
|